This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US Anesthesia Partners Holdings requests dismissal of amended complaint

( June 7, 2025, 00:39 GMT | Official Statement) -- MLex Summary: US Anesthesia Partners Holdings and US Anesthesia Partners of Texas have moved for dismissal of an amended complaint challenging an alleged anticompetitive scheme to monopolize hospital anesthesia services in Texas. "It takes more than copy-pasted, everyone-did-everything allegations to state a claim under the antitrust laws. But that is all plaintiffs offer in their amended complaint," the defendants said in their motion to dismiss, filed today in the Southern District of Texas. "Rather than allege what either Holdings or Texas P.A. did, when they did it, or how it injured competition, plaintiffs take the allegations they previously made against just U.S. Anesthesia Partners, Inc. ('USAP') and now assert that every such action was actually taken by all three defendants 'function[ing] as a single entity with a shared identity.'" See motion attached....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections